When cancer starts in the uterus, it is called uterine cancer. The uterus is the pear-shaped organ in a woman's pelvis (the area below your stomach and in between your hip bones). The uterus, also called the womb, is where the baby grows when a woman is pregnant. The most common type of uterine cancer is also called endometrial cancer because it forms in the lining of your uterus, called the endometrium.
When uterine cancer is found early, treatment is most effective. The most common sign of uterine cancer is bleeding that is not normal for you because of when it happens or how heavy it is. This could mean bleeding, even a little bit, after you have gone through menopause; periods that are longer than seven days; bleeding between periods; or any other bleeding that is longer or heavier than is normal for you.
Other symptoms, such as pain or pressure in your pelvis, also may occur if you have uterine cancer. If you have any of these symptoms, talk to your doctor, nurse, or other health care professional right away. They may be caused by something other than cancer, but the only way to know is to see your health care professional.
Below are comments from Len Lichtenfeld, MD, American Cancer Society deputy chief medical officer, in response to the results of the STAR trial.
According to drug company Lilly it's osteoporosis drug Evista is as effective as Tamoxifen in reducing the risk of breast cancer in high-risk women.
Laparoscopy proves safe, reduces hospital stay, and results in improved quality of life.
According to a new study released this week, women at high risk for breast cancer who take the well-known drug Tamoxifen, can reduce their long-term risk of developing the disease.
Cline said there has been much debate about whether high levels of dietary soy are safe for postmenopausal women. Soy products are sometimes sold as a natural alternative to traditional estrogen therapy, which does increase the risk of endometrial cancer.
"Our study defines a standard of care for this aggressive and growing form of uterine cancer," said Schwartz, who is also assistant chief of obstetrics and gynecology at Yale-New Haven Hospital. The procedure more accurately determines the complete stage and appropriate treatment and reduces the recurrence of the cancer.
Two similar comprehensive literature reviews and an editorial about the varying risk with different postmenopausal hormone therapy regimens have been published this month in Human Reproduction Update.
...and starting a family later in life increases risk of breast cancer and melanoma but reduces the risk of ovarian, cervix and uterine cancer according to an international study conducted by a team from The Queensland Institute of Medical Research (QIMR).
A new study suggests that, after surgery, all colon tumors should be tested to learn if the patient may have an inherited syndrome that carries an extremely high risk of cancer. It also suggests that this prescreening can be done using a relatively inexpensive microscopy test already used in hospital pathology laboratories.
In two studies of African-American women with endometrial cancer, a group of investigators from Walter Reed Army Medical Center and the National Cancer Institute has found that African-American women with advanced endometrial cancer have more aggressive tumors than Caucasian women, potentially leading to worse outcomes.
New research is shedding light on why estrogenic hormones produce unintended results in women, giving hope to the idea that new drugs might reach their targets and work more effectively. Ultimately it could mean that postmenopausal women would know that hormone-replacement therapy would have only its intended result.
The American Society for Therapeutic Radiology and Oncology has published a new patient information brochure Radiation Therapy for Gynecologic Cancers: Facts to Help People Understand Their Treatment Options to help educate patients and their families about the treatments available for gynecologic cancers.
Less radiation, delivered in a more tailored manner, is very effective and should be preferred over longer-term conventional radiation therapy in treating one of the most virulent forms of uterine cancer
As the saying goes “breast milk is best,” and more than 85 percent of new moms who give birth at the University of Michigan Health System agree and continue to breastfeed their new bundle of joy, on average, for the first six months.
Research in monkeys suggests the possibility that stress may increase risk for the most common type of uterine cancer, according to a report from Wake Forest University Baptist Medical Center.
New research in monkeys suggests that a diet high in the natural plant estrogens found in soy does not increase the risk of breast or uterine cancer in postmenopausal women.
Newest research findings were presented on the possible benefits they may provide for postmenopausal breast cancer risk reduction. SERMs are a class of drugs that can block the cell's ability to use estrogen to stimulate the development of breast cancer.
A Gynecologic Oncology Group (GOG) study, headed by Cornelia Trimble, M.D. of the Johns Hopkins Kimmel Cancer Center, has revealed that pathologists who evaluate uterine biopsies disagree 60 percent of the time on whether the specimens contain cancerous cells.
The controlled study is one of the largest ever to look at obesity in pregnancy, following more than 16,000 pregnant women at 14 medical centers across the country.